JP2006509186A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006509186A5 JP2006509186A5 JP2004541437A JP2004541437A JP2006509186A5 JP 2006509186 A5 JP2006509186 A5 JP 2006509186A5 JP 2004541437 A JP2004541437 A JP 2004541437A JP 2004541437 A JP2004541437 A JP 2004541437A JP 2006509186 A5 JP2006509186 A5 JP 2006509186A5
- Authority
- JP
- Japan
- Prior art keywords
- daltons
- biomarkers
- dalton
- protein
- computer program
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000090 biomarker Substances 0.000 claims 107
- 238000000034 method Methods 0.000 claims 78
- 102000004169 proteins and genes Human genes 0.000 claims 51
- 108090000623 proteins and genes Proteins 0.000 claims 51
- 238000004590 computer program Methods 0.000 claims 36
- 239000003463 adsorbent Substances 0.000 claims 28
- 206010060862 Prostate cancer Diseases 0.000 claims 25
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 25
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 claims 24
- 208000004403 Prostatic Hyperplasia Diseases 0.000 claims 24
- 238000003745 diagnosis Methods 0.000 claims 24
- 239000000523 sample Substances 0.000 claims 23
- 239000000758 substrate Substances 0.000 claims 14
- 238000001514 detection method Methods 0.000 claims 11
- 238000004949 mass spectrometry Methods 0.000 claims 10
- 238000001819 mass spectrum Methods 0.000 claims 8
- 238000003018 immunoassay Methods 0.000 claims 6
- 238000004458 analytical method Methods 0.000 claims 4
- 238000003066 decision tree Methods 0.000 claims 4
- 239000003480 eluent Substances 0.000 claims 4
- 238000001698 laser desorption ionisation Methods 0.000 claims 4
- 230000000717 retained effect Effects 0.000 claims 4
- 230000002596 correlated effect Effects 0.000 claims 3
- 102000004190 Enzymes Human genes 0.000 claims 2
- 108090000790 Enzymes Proteins 0.000 claims 2
- 239000013060 biological fluid Substances 0.000 claims 2
- 125000002091 cationic group Chemical group 0.000 claims 2
- 238000003795 desorption Methods 0.000 claims 2
- 238000004989 laser desorption mass spectroscopy Methods 0.000 claims 2
- 238000005259 measurement Methods 0.000 claims 2
- 239000002184 metal Substances 0.000 claims 2
- 210000000582 semen Anatomy 0.000 claims 2
- 206010036790 Productive cough Diseases 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 239000012530 fluid Substances 0.000 claims 1
- 210000004072 lung Anatomy 0.000 claims 1
- 210000002751 lymph Anatomy 0.000 claims 1
- 210000003097 mucus Anatomy 0.000 claims 1
- 210000002445 nipple Anatomy 0.000 claims 1
- 210000002307 prostate Anatomy 0.000 claims 1
- 210000003296 saliva Anatomy 0.000 claims 1
- 230000028327 secretion Effects 0.000 claims 1
- 210000002966 serum Anatomy 0.000 claims 1
- 210000003802 sputum Anatomy 0.000 claims 1
- 208000024794 sputum Diseases 0.000 claims 1
- 210000001138 tear Anatomy 0.000 claims 1
- 210000002700 urine Anatomy 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37901802P | 2002-05-10 | 2002-05-10 | |
| PCT/US2003/014432 WO2004030511A2 (en) | 2002-05-10 | 2003-05-09 | Prostate cancer biomarkers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006509186A JP2006509186A (ja) | 2006-03-16 |
| JP2006509186A5 true JP2006509186A5 (enExample) | 2006-06-08 |
Family
ID=32069592
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004541437A Pending JP2006509186A (ja) | 2002-05-10 | 2003-05-09 | 前立腺癌バイオマーカー |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20060088894A1 (enExample) |
| EP (1) | EP1575420A4 (enExample) |
| JP (1) | JP2006509186A (enExample) |
| AU (1) | AU2003294205A1 (enExample) |
| WO (1) | WO2004030511A2 (enExample) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL1014401C2 (nl) * | 2000-02-17 | 2001-09-04 | Stichting Tech Wetenschapp | Ceriumhoudend anorganisch scintillatormateriaal. |
| US7425700B2 (en) | 2003-05-22 | 2008-09-16 | Stults John T | Systems and methods for discovery and analysis of markers |
| US7689033B2 (en) * | 2003-07-16 | 2010-03-30 | Microsoft Corporation | Robust multi-view face detection methods and apparatuses |
| US7552035B2 (en) * | 2003-11-12 | 2009-06-23 | Siemens Corporate Research, Inc. | Method to use a receiver operator characteristics curve for model comparison in machine condition monitoring |
| EP1810198A1 (en) * | 2004-09-09 | 2007-07-25 | Université de Liège | Identification and use of biomarkers for the diagnosis and the prognosis of inflammatory diseases. |
| CA2593184A1 (en) | 2005-01-06 | 2006-07-13 | Eastern Virginia Medical School | Apolipoprotein a-ii isoform as a biomarker for prostate cancer |
| JPWO2007026773A1 (ja) * | 2005-08-31 | 2009-03-12 | 学校法人 久留米大学 | 医用診断処理装置 |
| US20080033253A1 (en) * | 2005-10-13 | 2008-02-07 | Neville Thomas B | Computer-implemented integrated health systems and methods |
| GB0601058D0 (en) * | 2006-01-19 | 2006-03-01 | Univ Southampton | Mast Cell Carboxypeptidase As A Marker For Anaphylaxis And Mastocytosis |
| CN101454331A (zh) * | 2006-03-24 | 2009-06-10 | 菲诺梅诺米发现公司 | 有效用于诊断前列腺癌的生物标记，及其方法 |
| EP2061899B1 (en) * | 2006-09-19 | 2012-08-29 | Metabolon Inc. | Biomarkers for prostate cancer and methods using the same |
| JP2008202978A (ja) * | 2007-02-16 | 2008-09-04 | Hirosaki Univ | 前立腺癌の診断方法 |
| CA2680556A1 (en) * | 2007-03-12 | 2008-09-18 | Miraculins Inc. | Biomarkers of prostate cancer and uses thereof |
| US20090088981A1 (en) * | 2007-04-26 | 2009-04-02 | Neville Thomas B | Methods And Systems Of Dynamic Screening Of Disease |
| WO2008154532A1 (en) * | 2007-06-11 | 2008-12-18 | California Pacific Medical Center | Method and kit for dynamic gene expression monitoring |
| EP2012127A3 (en) * | 2007-07-03 | 2009-03-11 | Koninklijke Philips Electronics N.V. | Diagnostic markers for detecting prostate cancer |
| JP5211753B2 (ja) * | 2008-02-27 | 2013-06-12 | 株式会社島津製作所 | クロマトグラフ用データ処理装置 |
| GB2464032A (en) * | 2008-05-15 | 2010-04-07 | Soar Biodynamics Ltd | Methods and systems for integrated health systems |
| US20100129785A1 (en) * | 2008-11-21 | 2010-05-27 | General Electric Company | Agents and methods for spectrometric analysis |
| US20100129787A1 (en) * | 2008-11-21 | 2010-05-27 | General Electric Company | Agents and methods for spectrometric analysis |
| US20100129795A1 (en) * | 2008-11-21 | 2010-05-27 | General Electric Company | Agents and methods for spectrometric analysis |
| JP2010127803A (ja) * | 2008-11-28 | 2010-06-10 | Systems Engineering Inc | 情報処理装置及び情報処理プログラム |
| US20100168621A1 (en) * | 2008-12-23 | 2010-07-01 | Neville Thomas B | Methods and systems for prostate health monitoring |
| US20110046919A1 (en) * | 2009-03-02 | 2011-02-24 | Juliesta Elaine Sylvester | Method for accurate measurement of enzyme activities |
| EP3444359A1 (en) | 2009-03-12 | 2019-02-20 | Cancer Prevention And Cure, Ltd. | Methods of identification of non-small cell lung cancer |
| US8214105B2 (en) * | 2009-08-21 | 2012-07-03 | Metra Electronics Corporation | Methods and systems for automatic detection of steering wheel control signals |
| EP2487251A1 (de) * | 2011-02-13 | 2012-08-15 | Protagen AG | Markersequenzen für die Diagnose von Prostatakarzinom und deren Verwendung |
| AU2012228365A1 (en) | 2011-03-11 | 2013-09-19 | Katholieke Universiteit Leuven, K.U.Leuven R&D | Molecules and methods for inhibition and detection of proteins |
| AU2012249288C1 (en) | 2011-04-29 | 2017-12-21 | Lung Cancer Proteomics Llc | Methods of identification and diagnosis of lung diseases using classification systems and kits thereof |
| US10417575B2 (en) * | 2012-12-14 | 2019-09-17 | Microsoft Technology Licensing, Llc | Resource allocation for machine learning |
| US8972328B2 (en) * | 2012-06-19 | 2015-03-03 | Microsoft Corporation | Determining document classification probabilistically through classification rule analysis |
| WO2014089431A1 (en) * | 2012-12-06 | 2014-06-12 | Dana-Farber Cancer Institute, Inc. | Metabolomic profiling defines oncogenes driving prostate tumors |
| WO2018187496A2 (en) | 2017-04-04 | 2018-10-11 | Lung Cancer Proteomics, Llc | Plasma based protein profiling for early stage lung cancer prognosis |
| WO2019046814A1 (en) | 2017-09-01 | 2019-03-07 | Venn Biosciences Corporation | IDENTIFICATION AND USE OF GLYCOPEPTIDES AS BIOMARKERS FOR THE DIAGNOSIS AND MONITORING OF TREATMENT |
| EP3773691A4 (en) * | 2018-03-29 | 2022-06-15 | Biodesix, Inc. | Apparatus and method for identification of primary immune resistance in cancer patients |
| AU2020326698A1 (en) | 2019-08-05 | 2022-02-24 | Seer, Inc. | Systems and methods for sample preparation, data generation, and protein corona analysis |
| CN112381155B (zh) * | 2020-11-17 | 2025-12-05 | 上海交通大学 | 基于人工智能的有机物样本处理方法、装置、设备及存储介质 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE242485T1 (de) * | 1993-05-28 | 2003-06-15 | Baylor College Medicine | Verfahren und massenspektrometer zur desorption und ionisierung von analyten |
-
2003
- 2003-05-09 US US10/513,649 patent/US20060088894A1/en not_active Abandoned
- 2003-05-09 EP EP03789686A patent/EP1575420A4/en not_active Withdrawn
- 2003-05-09 JP JP2004541437A patent/JP2006509186A/ja active Pending
- 2003-05-09 AU AU2003294205A patent/AU2003294205A1/en not_active Abandoned
- 2003-05-09 WO PCT/US2003/014432 patent/WO2004030511A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006509186A5 (enExample) | ||
| Won et al. | Pattern analysis of serum proteome distinguishes renal cell carcinoma from other urologic diseases and healthy persons | |
| AU2018332171B2 (en) | Volatile organic compounds as cancer biomarkers | |
| US20060088894A1 (en) | Prostate cancer biomarkers | |
| CN107064508A (zh) | 辅助结直肠癌早期诊断及预后监测的分子标志物及其应用 | |
| Zhang et al. | Tree analysis of mass spectral urine profiles discriminates transitional cell carcinoma of the bladder from noncancer patient | |
| Selevsek et al. | Systematic quantification of peptides/proteins in urine using selected reaction monitoring | |
| CN102803955B (zh) | 肝损伤的新标志物 | |
| CN112858551B (zh) | 用于诊断食管鳞癌的联合型代谢生物标志物的应用及试剂盒 | |
| Corradi et al. | Use of exhaled breath condensate to investigate occupational lung diseases | |
| JP2020510816A5 (enExample) | ||
| US20130040849A1 (en) | Method and kit for cancer diagnosis | |
| JP2007531879A (ja) | 肺癌バイオマーカー | |
| CN111279193B (zh) | 白塞氏病诊断试剂盒及检测尿中代谢物差异的方法 | |
| CN113777209A (zh) | 尿液中挥发性污染物暴露与效应标志物同步检测及应用 | |
| Guo et al. | Identification of serum biomarkers for pancreatic adenocarcinoma by proteomic analysis | |
| RU2013158667A (ru) | Способ диагностики болезни гоше | |
| US20070087392A1 (en) | Method for diagnosing head and neck squamous cell carcinoma | |
| US20030228639A1 (en) | Prostate cancer markers | |
| Xiao et al. | Discovery of laryngeal carcinoma by serum proteomic pattern analysis | |
| CN110824037A (zh) | Mit和/或dit作为甲状腺癌标志物的应用及试剂盒 | |
| WO2021245527A2 (en) | Real-time tracing of cytokine storm in blood serum of covid-19 patients | |
| JPWO2022072471A5 (enExample) | ||
| Sandoval et al. | Neuroblastoma detection using serum proteomic profiling: a novel mining technique for cancer? | |
| US20060204958A1 (en) | Methods for diagnosing htlv-i-mediated diseases |